The rationale for moderate TAM dosing was to trigger knockout rearrangement of floxed Sdhc genes in a low but detectable number of Sox10+ cells to test the hypothesis that each resulting SDH‐null adrenal medulla precursor cell might seed a PPGL tumor. The gene discussed is SDHB; the disease is neoplasm.